Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: January 29, 2022

Volunteer for clinical trials for BUMETANIDE at ClinicalTrialExchange

DrugPatentWatch Database Preview

BUMETANIDE Drug Patent Profile

Email this page to a colleague

« Back to Dashboard

When do Bumetanide patents expire, and what generic alternatives are available?

Bumetanide is a drug marketed by Athenex Inc, Hospira, Teva Parenteral, West-ward Pharms Int, Amneal Pharms Co, Heritage Pharma, Rising, Sandoz, Upsher Smith Labs, and Zydus Pharms. and is included in eleven NDAs.

The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the bumetanide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Bumetanide

A generic version of BUMETANIDE was approved as bumetanide by HOSPIRA on October 31st, 1994.

  Try it Free

Drug patent expirations by year for BUMETANIDE
Drug Prices for BUMETANIDE

See drug prices for BUMETANIDE

Drug Sales Revenue Trends for BUMETANIDE

See drug sales revenues for BUMETANIDE

Recent Clinical Trials for BUMETANIDE

Identify potential brand extensions & 505(b)(2) entrants

Victor Chang Cardiac Research InstitutePhase 4
St Vincent's Centre for Applied Medical ResearchPhase 4
The George InstitutePhase 4

See all BUMETANIDE clinical trials

Pharmacology for BUMETANIDE
Medical Subject Heading (MeSH) Categories for BUMETANIDE
Anatomical Therapeutic Chemical (ATC) Classes for BUMETANIDE

US Patents and Regulatory Information for BUMETANIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Athenex Inc BUMETANIDE bumetanide INJECTABLE;INJECTION 074441-001 Jan 27, 1995 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Upsher Smith Labs BUMETANIDE bumetanide TABLET;ORAL 209916-001 Jan 23, 2018 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-002 Oct 18, 2017 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.